Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07332156
Eligibility Criteria:
Inclusion Criteria:
* Adults aged ≥40 years with prior COPD (from 2009) and newly diagnosed diabetes who initiated SU or SGLT2i between January 1, 2014 and December 31, 2023
Exclusion Criteria:
* Pre-existing
* ESRD
* Cancer
* Concurrent prescribing of the study drugs at the index date
* Exposure to the drugs of interest during the year preceding the index date
* Death or cancer incidence within a month
In the sensitivity analysis, we are planning to substitute sulfonylurea to DPP4 inhibitors.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT07332156
Study Brief:
Protocol Section:
NCT07332156